General Overview of Endocrine Role
The kidneys are not only excretory organs but also a vital component of humoral regulation. The key areas of their endocrine activity are participation in hematopoiesis (blood cell formation) and comprehensive regulation of blood pressure (BP). To accomplish these tasks, renal tissue synthesizes specific compounds that control both the cellular composition of blood and overall vascular tone.
Regulation of Erythropoiesis
Erythropoietin is responsible for controlling the formation of blood cells.
Its mechanism of action is strictly specific:
- The hormone enters the systemic circulation and reaches its primary target — the red bone marrow.
- In the bone marrow tissue, erythropoietin stimulates the earliest stages of erythropoiesis.
- As a result, the production of new erythrocytes is activated, maintaining adequate tissue gas exchange.
Increasing Blood Pressure: The Renin System
To control vascular tone, the kidneys secrete substances with opposing effects. The primary pressor agent is renin. It is important to understand that unlike classical hormones, renin is enzymatic in nature.
It triggers a cascade known as the renin-angiotensin system (RAS):
- In the bloodstream, renin catalyzes the cleavage of angiotensinogen, a protein continuously synthesized by the liver.
- An inactive precursor peptide is formed.
- A two-step conversion takes place, culminating in the appearance of the active form — angiotensin II.
Effects of Angiotensin II:
- Direct narrowing of the vascular lumen (vasoconstriction).
- Stimulation of the adrenal glands, which begin to actively secrete aldosterone.
- Aldosterone causes the retention of water and sodium in the body.
The result of this mechanism is a powerful increase in blood pressure.
Decreasing Blood Pressure: Prostaglandins
Prostaglandins serve as the physiological counterpart to the renin system. Although these substances are produced in many organs of the human body, their specific renal fraction exerts pronounced local and systemic effects on hemodynamics.
Unlike angiotensin II, the release of renal prostaglandins leads to vasodilation. Their net effect is a reduction in blood pressure, which protects the renal tissue from ischemia and curbs excessive vasoconstriction.